The Superdisintegrants Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The superdisintegrants market has seen notable expansion recently. The market value, initially at $1.09 billion in 2024, is predicted to climb to $1.16 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 6.5%.
The superdisintegrants market is predicted to grow to a size of $1.48 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.3%.
Download Your Free Sample of the 2025 Superdisintegrants Market Report and Uncover Key Trends Now!The key drivers in the superdisintegrants market are:
• Rising demand for oral solid dosage forms
• Growth in chronic disease prevalence
• Expansion of pharmaceutical manufacturing
• Advancements towards natural and biodegradable superdisintegrants
The superdisintegrants market covered in this report is segmented –
1) By Type: Natural Superdisintegrants, Synthetic Superdisintegrants, Other Superdisintegrants
2) By Formulation: Tablets, Capsules
3) By Therapeutic Area: Gastrointestinal Diseases, Neurological Diseases, Oncology, Infectious Diseases, Cardiovascular Diseases, Hematological Diseases
Subsegments:
1) By Natural Superdisintegrants: Starch, Cellulose, Chitosan, Gums, Other Natural Superdisintegrants
2) By Synthetic Superdisintegrants: Cross-linked Polyvinylpyrrolidone (Crospovidone), Sodium Starch Glycolate, Croscarmellose Sodium, Other Synthetic Superdisintegrants
3) By Other Superdisintegrants: Ion Exchange Resins, Surfactant-Based Superdisintegrants, Other Specialized Superdisintegrants
The key trends in the superdisintegrants market are:
• Technological innovations are being integrated into manufacturing techniques.
• There is a growing shift towards natural and biodegradable superdisintegrants.
• The development of novel drug-delivery systems is a prominent trend.
• Collaborations between excipients and pharmaceutical companies are on the rise.
Major players in the superdisintegrants market are:
• BASF SE
• Merck KGaA
• DuPont de Nemours Inc.
• IFF Pharma Solutions
• Ingredion Incorporated
• Roquette Freres SA.
• FMC Corporation
• Azelis Group
• Ashland Inc.
• Piramal Healthcare
• Colorcon Inc. Ltd.
• Boai NKY Pharmaceuticals Ltd.
• JRS Pharma
• Faran Shimi Pharmaceutical
• DFE Pharma India Private Limited.
• Sigachi Industries Limited
• Corel Pharma Chem
• Maple Biotech Pvt. Ltd.
• Shanghai Chineway Pharmaceutical Technology Co. Ltd.
• JH Nanhang Life Sciences Co. Ltd.
North America was the largest region in the superdisintegrants market in 2024